Turtle Creek Wealth Advisors’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
Turtle Creek Wealth Advisors's EW Position: Q2 2026 in Review
Turtle Creek Wealth Advisors increased its Edwards Lifesciences (EW) stake by 6.6% in Q2 2026, buying an estimated $24.5K and bringing the position to 4,740 shares worth $429K. The position accounts for 0.02% of the portfolio, ranked #288.
Turtle Creek Wealth Advisors first reported a position in EW in Q4 2023 and has held it in 6 quarters since. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- Turtle Creek Wealth Advisors held 4,740 shares of Edwards Lifesciences worth $429K as of Q2 2026.
- Turtle Creek Wealth Advisors bought 292 Edwards Lifesciences shares in Q2 2026, an estimated $24.5K.
- Edwards Lifesciences made up 0.02% of Turtle Creek Wealth Advisors's portfolio in Q2 2026, its #288 holding.
- Turtle Creek Wealth Advisors first reported a position in Edwards Lifesciences in Q4 2023 and has held it in 6 quarters since.
- 1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on Turtle Creek Wealth Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.